Terms: = Endocrine gland cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Prognosis
12 results:
1. Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab.
Verleye L; Castanares-Zapatero D; Devos C; De Gendt C; Silversmit G; Van Damme N; Hulstaert F; Thiry N; Neyt M
Int J Gynecol Cancer; 2023 Apr; 33(4):543-548. PubMed ID: 36604121
[TBL] [Abstract] [Full Text] [Related]
2. Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype.
Celada L; Cubiella T; San-Juan-Guardado J; Gutiérrez G; Beiguela B; Rodriguez R; Poch M; Astudillo A; Grijalba A; Sánchez-Sobrino P; Tous M; Navarro E; Serrano T; Paja M; Valdés N; Chiara MD
J Pathol; 2023 Jan; 259(1):103-114. PubMed ID: 36314599
[TBL] [Abstract] [Full Text] [Related]
3. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract] [Full Text] [Related]
4. Personalized Management of Pheochromocytoma and Paraganglioma.
Nölting S; Bechmann N; Taieb D; Beuschlein F; Fassnacht M; Kroiss M; Eisenhofer G; Grossman A; Pacak K
Endocr Rev; 2022 Mar; 43(2):199-239. PubMed ID: 34147030
[TBL] [Abstract] [Full Text] [Related]
5. Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis.
Crona J; Lamarca A; Ghosal S; Welin S; Skogseid B; Pacak K
Endocr Relat Cancer; 2019 May; 26(5):539-550. PubMed ID: 30893643
[TBL] [Abstract] [Full Text] [Related]
6. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
[TBL] [Abstract] [Full Text] [Related]
7. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.
Huang L; Jansen L; Balavarca Y; Babaei M; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Primic-Žakelj M; Zadnik V; Besselink MG; Schrotz-King P; Brenner H
BMC Med; 2018 Aug; 16(1):125. PubMed ID: 30126408
[TBL] [Abstract] [Full Text] [Related]
8. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic cancer Metastasis.
Wang X; Luo G; Zhang K; Cao J; Huang C; Jiang T; Liu B; Su L; Qiu Z
Cancer Res; 2018 Aug; 78(16):4586-4598. PubMed ID: 29880482
[TBL] [Abstract] [Full Text] [Related]
9. Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer.
Zhang Q; Lou Y; Zhang J; Fu Q; Wei T; Sun X; Chen Q; Yang J; Bai X; Liang T
Mol Cancer; 2017 Jul; 16(1):119. PubMed ID: 28705232
[TBL] [Abstract] [Full Text] [Related]
10. Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.
Därr R; Nambuba J; Del Rivero J; Janssen I; Merino M; Todorovic M; Balint B; Jochmanova I; Prchal JT; Lechan RM; Tischler AS; Popovic V; Miljic D; Adams KT; Prall FR; Ling A; Golomb MR; Ferguson M; Nilubol N; Chen CC; Chew E; Taïeb D; Stratakis CA; Fojo T; Yang C; Kebebew E; Zhuang Z; Pacak K
Endocr Relat Cancer; 2016 Dec; 23(12):899-908. PubMed ID: 27679736
[TBL] [Abstract] [Full Text] [Related]
11. Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness.
Raspaglio G; Petrillo M; Martinelli E; Li Puma DD; Mariani M; De Donato M; Filippetti F; Mozzetti S; Prislei S; Zannoni GF; Scambia G; Ferlini C
Gene; 2014 Jun; 542(2):173-81. PubMed ID: 24661907
[TBL] [Abstract] [Full Text] [Related]
12. Testicular self-examination: teaching, learning and practice by nurses.
Stanford J
J Adv Nurs; 1987 Jan; 12(1):13-9. PubMed ID: 3643935
[TBL] [Abstract] [Full Text] [Related]
